Mirae Asset Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1296 Cr | ₹2762 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 02 Jul 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 15% |
| Expense Ratio | 2.14 | 1.92 |
| Manager | Meeta Shetty | Vrijesh Kasera |
| ISIN Code | INF277K016A9 | INF769K01EA2 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Month | -0.42% | -1.3% |
| 6 Month | 7.15% | 7.88% |
| 1 Year | 1.77% | 1.34% |
| 3 Year | 21.91% | 20.69% |
| 5 Year | 17.97% | 17.6% |
SIP Return Analysis
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 6 Month | 1.48% | 1.15% |
| 1 Year | 7.11% | 7.31% |
| 3 Year | 19.19% | 18.97% |
| 5 Year | 17.54% | 16.78% |
Rolling Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Year | 8.89% | 19.65% |
| 3 Year | 18.72% | 20.28% |
| 5 Year | 15.51% | 23.35% |
Risk Management
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Standard Deviation | 16.04% | 16.44% |
| Sharp | 0.90% | 0.82% |
| Beta | 0.97% | 1.00% |
| Alpha | -0.83% | -2.05% |
Fund Managers
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Name | Meeta Shetty | Vrijesh Kasera |
| Total AUM | ₹17847 Cr | ₹12061 Cr |
| Funds Managed | 5 | 4 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 4.14 | 4.78 |
| Large Cap | 25.14 | 32.37 |
| Mid Cap | 37.44 | 36.93 |
| Small Cap | 33.28 | 25.92 |
Sector Allocation
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 1.72 | 0.11 |
| Healthcare | 94.07 | 98.51 |
| Basic Materials | 2.64 | 1.38 |
| Financial Services | 1.58 | - |
Top Comparisons
SBI Dividend Yield Fund - Regular Plan - Growth
3Y Returns0%
Tata Dividend Yield Fund-Regular Plan-Growth
3Y Returns17.72%
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund - Growth
3Y Returns21.22%
Axis Global Innovation Fund of Fund - Regular Plan - Growth
3Y Returns22.94%
Bandhan Value Fund - Regular Plan - Growth
3Y Returns17.29%
Axis Value Fund - Regular Plan - Growth
3Y Returns22.51%
ICICI Prudential Nifty Next 50 Index Fund - Growth
3Y Returns17.2%
Motilal Oswal Nifty Smallcap 250 Index - Regular Plan
3Y Returns21.23%